Equity · Financial Services
GL
NYSEGlobe Life (GL)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for GL to draw a line in its place.
- Market cap
- $14.2B
- P/E (TTM)
- 12.3
- 52-week range
- $117.92 – $185
- Avg volume
- 132.9K
as of Jul 17, 2026
Have Globe Life (GL) insiders bought or sold shares recently?
In the 90 days to 28 Oct 2026, Globe Life insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 25 Feb 2026, show no open-market purchase.
Form 4, 90 days to 28 Oct 2026, newest reported trade 23 Oct 2026
Buys 0Sells 5Net sold $21.04MOther filings 4
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 23 Oct 2026 | MAJORS MICHAEL CLAYEVP - Chief Strategy Officer | Sell | 14,377 | $2.22M |
| 22 Sep 2026 | Hensley Robert EdwardEVP & Chief Investment Officer | Sell | 10,000 | $1.70M |
| 07 Aug 2026 | MITCHELL ROBERT BRIANEVP, General Counsel and CRO | Sell | 23,000 | $4.22M |
| 31 Jul 2026 | Darden James MatthewCo-Chairman & CEO | Sell | 50,000 | $9.12M |
| 30 Jul 2026 | Kalmbach Thomas PeterEVP & CFO | Sell | 21,000 | $3.78M |
| Sold | 5 open-market sales | 118,377 | $21.04M |
4 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 22 Sep 2026 | Hensley Robert EdwardEVP & Chief Investment Officer | Option exercise | 10,000 | $1.03M |
| 07 Aug 2026 | MITCHELL ROBERT BRIANEVP, General Counsel and CRO | Option exercise | 23,000 | $2.37M |
| 31 Jul 2026 | Darden James MatthewCo-Chairman & CEO | Option exercise | 50,000 | $4.92M |
| 30 Jul 2026 | Kalmbach Thomas PeterEVP & CFO | Option exercise | 21,000 | $2.36M |
Which funds hold Globe Life (GL)?
10 of the 45 institutional funds we track reported a Globe Life position for the quarter ended 30 Jun 2026 — a combined $407.8M; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| AQR Capital Management | Added | 1,515,987 | $270.9M | +26.6% |
| Two Sigma Investments | Added | 308,323 | $55.1M | +196.6% |
| Millennium Management | Held (±25%) | 184,772 | $33.0M | +20.5% |
| Citadel Advisors | Trimmed | 125,122 | $22.4M | −50.4% |
| Bridgewater Associates | Added | 66,120 | $11.8M | +1,190.4% |
| Marshall Wace | Added | 61,638 | $11.0M | +835.0% |
| Balyasny Asset Management | Trimmed | 11,642 | $2.1M | −90.5% |
| Man Group | Trimmed | 3,641 | $651K | −90.0% |
| D. E. Shaw & Co. | Held (±25%) | 3,605 | $644K | +19.0% |
| Fisher Asset Management | New position | 1,618 | $289K |
Have members of Congress traded Globe Life (GL)?
The most recent congressional trade disclosed in Globe Life is a sale by Lisa C. McClain (house, MI), dated 10 Jul 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 10 Jul 2025 | Lisa C. McClainhouse · Republican–MI | Sale | $1K–$15K | 34 days |
| 17 Jun 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | $1K–$15K | 57 days |
| 08 Sep 2023 | Lois Frankelhouse · Democrat–FL | Sale | $1K–$15K | 32 days |
| 02 Jun 2023 | Lois Frankelhouse · Democrat–FL | Sale | $1K–$15K | 22 days |
What has been filed or recorded for Globe Life (GL)?
The filings we hold for Globe Life, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 25 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 25 Sep 2026 | Fails to deliver | Shares failed to deliver | 95 shares | $16K notional · <0.001% of shares out |
| 24 Sep 2026 | Fails to deliver | Shares failed to deliver | 82 shares | $14K notional · <0.001% of shares out |
| 23 Sep 2026 | Fails to deliver | Shares failed to deliver | 4,962 shares | $841K notional · 0.006% of shares out |
| 22 Sep 2026 | Fails to deliver | Shares failed to deliver | 82 shares | $14K notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS $3.65 | Revenue $1.60B |
| 30 Jun 2026 | Financials | Total assets | $31.6B | at period end |
| 30 Jun 2026 | Financials | Total equity | $6.2B | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS $3.39 | Revenue $1.56B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS $14.07 | Revenue $5.99B |
| 31 Dec 2025 | Financials | Revenue | $6.0B | fiscal year |
| 31 Dec 2025 | Financials | Net income | $1.2B | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | $14.07 | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS $4.73 | Revenue $1.51B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS $3.05 | Revenue $1.48B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS $3.01 | Revenue $1.48B |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS $11.94 | Revenue $5.78B |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS $3.44 | Revenue $1.46B |
Globe Life (GL): frequently asked questions
What is Globe Life’s market cap?
Globe Life is worth $14.2B by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is Globe Life’s P/E ratio?
Globe Life has a price-to-earnings ratio of 12.3, as of 17 Jul 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Globe Life’s revenue?
Globe Life reported revenue of $6.0B for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Globe Life insiders bought or sold shares recently?
In the 90 days to 28 Oct 2026, Globe Life insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 25 Feb 2026, show no open-market purchase. A further 4 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Globe Life?
10 of the 45 funds we track reported a Globe Life position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Two Sigma Investments and Millennium Management. See Funds
Have members of Congress traded Globe Life?
Yes. 4 trades in Globe Life appear in the congressional disclosures we hold; the latest is a sale by Lisa C. McClain (House, MI) dated 10 Jul 2025, filed 13 Aug 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Globe Life last report earnings?
Globe Life last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of $3.65; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings